跳至主要内容
临床试验/NCT01067742
NCT01067742终止不适用

The Natural History of Mucolipidosis Type IV

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2009年2月19日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
7
试验地点
1
主要终点
Neuropsychological testing

研究概览

简要总结

The purpose of this study is to define the natural history of Mucolipidosis Type IV and identify potential clinical outcome measures.

详细描述

Mucolipidosis type IV (MLIV) is an autosomal recessive disorder typically characterized by severe psychomotor delay evident by the end of the first year of life and slowly progressive visual impairment during the first decade as a result of a combination of corneal clouding and retinal degeneration. By the end of the first decade of life, and always by their early teens, individuals with typical MLIV develop severe visual impairment as a result of retinal degeneration. MLIV is an under-diagnosed and unique lysosomal disorder in that it often is mistaken either for cerebral palsy or for a retinal dystrophy of unknown cause. In addition, it is caused by a defect in a cation channel rather than by a lysosomal hydrolase. This study represents the only prospective clinical study in this patient population. Now that an animal model has been created and novel therapies will likely be tested, it is particularly important to define the natural history of this disorder and identify potential clinical outcome measures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 64 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must:
  • Have a definitive diagnosis of MLIV based at least on a compatible history and significantly elevated blood gastrin levels
  • Be able to travel to the Baylor Institute of Metabolic Disease in Dallas and spend 2-3 working days on site
  • Be able to tolerate a general exam and neurological exam
  • Be able to tolerate a modest amount of blood drawing, provide a urine specimen, and have a skin biopsy(if not previously done)
  • Be able to tolerate the performance of necessary neuroimaging studies to include EEG and Head MRI
  • Be able to tolerate a neuropsychological testing and rehabilitation evaluation

排除标准

  • 未提供

研究组 & 干预措施

Subjects with Mucolipidosis Type IV

结局指标

主要结局

Neuropsychological testing

时间窗: Annual by 5 years

次要结局

  • Blood tests(Annual by 5 years)
  • Urine tests(Annual by 5 years)
  • MRI of the brain(Annual by 5 years)
  • Rehabilitation evaluation(Annual by 5 years)
  • Nutritional status evaluation(Annual by 5 years)
  • Skin biopsy(1 year only)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验